1. Home
  2. KNSA vs ROCK Comparison

KNSA vs ROCK Comparison

Compare KNSA & ROCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • ROCK
  • Stock Information
  • Founded
  • KNSA 2015
  • ROCK 1972
  • Country
  • KNSA United Kingdom
  • ROCK United States
  • Employees
  • KNSA N/A
  • ROCK N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • ROCK
  • Sector
  • KNSA Health Care
  • ROCK
  • Exchange
  • KNSA Nasdaq
  • ROCK Nasdaq
  • Market Cap
  • KNSA 1.9B
  • ROCK 1.5B
  • IPO Year
  • KNSA 2018
  • ROCK 1993
  • Fundamental
  • Price
  • KNSA $27.36
  • ROCK $58.58
  • Analyst Decision
  • KNSA Strong Buy
  • ROCK
  • Analyst Count
  • KNSA 5
  • ROCK 0
  • Target Price
  • KNSA $38.80
  • ROCK N/A
  • AVG Volume (30 Days)
  • KNSA 474.9K
  • ROCK 318.9K
  • Earning Date
  • KNSA 07-22-2025
  • ROCK 04-30-2025
  • Dividend Yield
  • KNSA N/A
  • ROCK N/A
  • EPS Growth
  • KNSA N/A
  • ROCK 16.71
  • EPS
  • KNSA N/A
  • ROCK 4.34
  • Revenue
  • KNSA $481,166,000.00
  • ROCK $1,306,273,000.00
  • Revenue This Year
  • KNSA $37.21
  • ROCK $11.02
  • Revenue Next Year
  • KNSA $5.32
  • ROCK $8.19
  • P/E Ratio
  • KNSA N/A
  • ROCK $13.49
  • Revenue Growth
  • KNSA 59.45
  • ROCK N/A
  • 52 Week Low
  • KNSA $17.38
  • ROCK $48.96
  • 52 Week High
  • KNSA $28.56
  • ROCK $81.90
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 62.48
  • ROCK 49.22
  • Support Level
  • KNSA $26.28
  • ROCK $57.88
  • Resistance Level
  • KNSA $27.90
  • ROCK $60.85
  • Average True Range (ATR)
  • KNSA 0.99
  • ROCK 1.45
  • MACD
  • KNSA -0.07
  • ROCK -0.27
  • Stochastic Oscillator
  • KNSA 82.30
  • ROCK 12.24

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About ROCK Gibraltar Industries Inc.

Gibraltar Industries Inc manufactures and provides products and services for the Renewable energy, Residential, Agtech, and Infrastructure markets. The Renewables Segment is engaged in designing, engineering, manufacturing, and installing solar racking and electrical balance systems. Agtech Segment provides growing and processing solutions including the designing, engineering, manufacturing, full-scope construction, maintenance, and support of greenhouses and indoor growing operations, and botanical extraction systems. It derives key revenue from the Residential segment which offers roof and foundation ventilation products, single point and centralized mail systems electronic package solutions, and Retractable awnings and gutter guards, among other products.

Share on Social Networks: